Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole in Children With Autism
NCT03866668Phase 2Recruiting
- Sponsor
- Stanford University
- Start
- May 2019
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of esomeprazole in Autism Spectrum Disorder (ASD), sponsored by Stanford University. Primary endpoint: Social Responsiveness Scale, 2nd Edition at 8 weeks. Started May 2019; status: recruiting.
02
Drugs
esomeprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03866668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03866668.